GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION
|
|
- Clifford Jones
- 6 years ago
- Views:
Transcription
1 GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1 Combating Tuberculosis: Principles for Accelerating DOTS coverage [1999] 2 Toman s Tuberculosis: Case detection, treatment and monitoring, 2 nd Ed [2004] 3 An Expanded DOTS Framework for effective Tuberculosis Control [2002] df 4 TB/HIV Clinical Manual, 2 nd Ed [2004] 5 Guidelines for HIV surveillance among tuberculosis patients 2 nd Ed [2004] 6 Guidelines for surveillance of drug resistance in tuberculosis [2003] _320/surveillance_guidelinespdf.pdf 7 Treatment of Tuberculosis guidelines for national programmes - Third edition [2003] 7a Revised Chapter 4 from the: Treatment of Tuberculosis: Guidelines for National Programmes. Third edition [2003] 8 A guide for Tuberculosis Treatment Supporters [2002] pdf 9 Guidelines for Workplace TB Control [2003] 10 Anti-Tuberculosis Drug Resistance in the World [2004] _report_exec.pdf 11 DOTS-Plus: preliminary results and emerging issues [2002] 12 Global Plan to Stop TB [2003] 1
2 obalplan_en.pdf 13 Public-Private Mix for DOTS: Practical tools to help implementation [2003] pdf 14 Involving Private Practitioners in Tuberculosis Control [2001] /PrivatePractitionnersWHO285.pdf 15 What is DOTS? - A guide to understanding the WHO-recommended TB control strategy known as OTS.pdf DOTS [1999] 16 Guidelines for the prevention of tuberculosis in health care facilities in resource-limited settings [1999] 17 Multidrug resistant tuberculosis (MDR-TB): Basis for the development of an evidence-based casemanagement 0.pdf strategy for MDR-TB within the WHO's DOTS strategy [1999] 18 Tuberculosis handbook [1998] 8_253-en.pdf 19 Guidelines for conducting a review of a national tuberculosis programme [1998] pdf 20 Policy Statement on Preventive Therapy Against Tuberculosis in People Living with HIV [1998] bhivpolicy.pdf 21 A strategic framework to decrease the burden of TB/HIV [2002] hiv_2002_296_en.pdf 22 Interim policy on collaborative TB/HIV activities [2004] 23 TB control in refugee situations [1997] 24 Guidelines for the control of TB in prisons [1998] 25 Guidelines for the management of drug-resistant TB [1997] f 26 Tuberculosis Control: an Annotated Bibliography [2001] 27 European framework to decrease the burden of TB/HIV [2003] 28 European framework for tuberculosis control and elimination in countries with a low incidence [2002] ow=&hits=10&hits=10&resultformat=&fulltext=tuber culosis&andorexactfulltext=and&searchid=
3 29 A guide to monitoring and evaluation for collaborative TB/HIV activities [2004] 30 Laboratory services in tuberculosis control: Part I: Organization and Management [1998] Laboratory services in tuberculosis control: Part II: Microscopy [1998] Laboratory services in tuberculosis control: Part III: Culture [1998] _15&stored_search=&FIRSTINDEX=0&sortspec=relevance &resourcetype=1&journalcode=erj Centers for Disease Control (CDC), USA 31 Core Curriculum on Tuberculosis, 4 th Ed [2000] CoreCurriculumonTB.pdf 32 Anergy Skin Testing and Preventive Therapy for HIV-Infected Persons: Revised Recommendations. [1997] 33 The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States [1996] 34 Progressing Toward Tuberculosis Elimination in Low-Incidence Areas of the United States [2002] 35 Tuberculosis Elimination Revisited: Obstacles, Opportunities, and a Renewed Commitment [1999] 36 Essential Components of a Tuberculosis Prevention and Control Program [1995] 37 Recommendations for Prevention and Control of Tuberculosis among Foreign-Born Persons [1998] 38 Prevention and Control of Tuberculosis in Correctional Facilities [1996] 39 Screening for Tuberculosis and Tuberculosis Infection in High-Risk Populations [1995] 40 Prevention and Control of Tuberculosis Among Homeless Persons [1992] 41 Guidelines for Environmental Infection Control in Health-Care [2003] m 3
4 m m American Thoracic Society 42 Guidelines for Preventing the transmission of Mycobacterium tuberculosis in Health-Care Facilities [1994] 43 National Action Plan to Combat Multidrug-Resistant Tuberculosis [1992] 44 Management of Persons Exposed to Multidrug- Resistant Tuberculosis [1992] 45 Guidelines for Using the QuantiFERON -TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection [2003] 46 Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors [2004] 47 Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection [2003] 48 Treatment of Tuberculosis. American Thoracic Society, CDC, and Infectious Diseases Society of America [2002] 49 Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection [1999] 50 Diagnostic Standards and Classification of Tuberculosis in Adults and Children [1999] 51 Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria [1997] 52 Rapid Diagnostic Test for Tuberculosis: What is the Appropriate Use? [1997] 53 Institutional Control Measures for Tuberculosis in the Era of Multiple Drug Resistance [1995] 54 Treatment of Tuberculosis and Tuberculosis 4
5 Infection in Adults & Children [1994] 55 Control of tuberculosis in the United States [1992] International Union Against Tuberculosis & Lung Disease 56 Management of Tuberculosis: a Guide for Low Income Countries [2000] 57 Technical Guide: Sputum Examination for Tuberculosis by Direct Microscopy in Low Income Countries [2000] 58 Interventions for Tuberculosis Control and Elimination [2002] nt_of_tb.pdf _guide.pdf ns.pdf 59 Tuberculosis A Manual for Medical Students [2003] pdf 60 A Tuberculosis Guide for Specialist Physicians - part 1 3 [2004] Epidemiologic Basis of Tuberculosis Control [1999] 62 The Public Health Service National Tuberculosis Reference Laboratory and the National Laboratory Network [1998] 63 Tuberculosis Programs Review, Planning, Technical Support: A manual of methods and procedures [1998] gic_basis.pdf th_service.pdf ms.pdf European Respiratory Society 64 Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region [1999] Dept of Human Services, Victoria, Australia 5
6 65 Management, prevention and control of tuberculosis: Guidelines for health care providers de.pdf Canadian Lung Association, Canadian Thoracic Society & Centre for Infectious Disease Prevention, Health Canada 66 Canadian Tuberculosis Standards. 5 th Edition [2000] 67 Guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arriving in Canada: a summary. [2003] EuroTB 68 EuroTB : European recommendations on TB surveillance: Surveillance of tuberculosis in Europe [1996] Standardisation of antituberculosis drug resistance surveillance in Europe Standardised tuberculosis treatment outcome in Europe htm Indian Academy of Paediatrics 69 Consensus Statement on Diagnosis of Childhood Tuberculosis [2004] Global Health Council 70 Research Brief Preventing Tuberculosis in HIVinfected Persons [2004] 71 Evidence for Action: Lack of Evidence that Directly Observed Therapy (DOT) Improves Cure or Treatment Completion Rates in Patients with pdf 6
7 Tuberculosis [2001] New Zealand Ministry of Health 72 Guidelines for Tuberculosis Control in New Zealand [2003] 256C86006ED394/$File/TBControlGuidelines03.pdf 73 DOTS for tuberculosis [2001] d47d0/257b42d9ef210e62cc2569ec007cb62f/$FILE /DOTTBDoc.pdf British Thoracic Society 74 Control and prevention of tuberculosis in the United Kingdom: Code of Practice [2000] 75 Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999 [2000] 76 Chemotherapy and management of tuberculosis in the United Kingdom: recommendations [1998] Department of Health, UK 77 Stopping tuberculosis in England [2004] Georgia Division of Public Health 78 Tuberculosis Reference Guide [2001] Infectious Diseases Society of America (IDSA) 79 Practice Guidelines for the Treatment of Tuberculosis [2000] / web.pdf Institute of Medicine, USA 80 Tuberculosis in the workplace [2001] 7
8 81 Ending Neglect: Elimination of tuberculosis in the US [2000] UMDNJ National TB Center 82 Management of latent tuberculosis infection in children [2004] 83 Guidelines for the diagnosis of latent tuberculosis infection [2002] 84 Guidelines for Initiating a School-Based Directly Observed Therapy Program [2002] 85 Treating the Patient with Tuberculosis: Guidelines for Collaborating with Community Physicians [2003] f US Preventive Services Task Force 86 Screening for Tuberculosis Infection [1996] Revised National Tuberculosis Control Program, India 87 Technical Guidelines for Tuberculosis Control [2000] 88 Operational Guidelines for Tuberculosis Control [2000] 89 TB-HIV:A Guide for Health Worker 90 Consensus statement of management of Pediatric TB under RNTCP [2003] f%20management%20of%20paediatric%20tb%20under% 20RNTCP.pdf 91 NGO Guidelines 92 A guide for practicing physicians 93 A guide for medical officers Francis J Curry National TB Center, San Francisco 94 A Guideline for Establishing Effective Practices: Identifying Persons with Infectious TB in the Emergency Department [1999] gencyroomguidelines.pdf 8
9 95 Policy and Procedures for Tuberculosis Screening of Healthcare Workers [1999] 96 Treating Latent Tuberculosis Infection in Key High- Risk Communities Sociedad Argentina de Pediatría. Comité Nacional de Neumonología y Comité Nacional de Infectología 97 Criterios de diagnóstico y tratamiento de la tuberculosis infantil / Diagnostic and therapeutic criteria for the management of tuberculosis in childhood [2002] eening.pdf fm?productid=wpt- 06%20B&subSec=Workplace%20Tools 9
10 PART II. GROUPED BY TOPICS Topic (area of focus) Name of the Guide/Statement Available at Epidemiology & Surveillance 1 Epidemiologic Basis of Tuberculosis Control [1999] 2 EuroTB : European recommendations on TB surveillance ogic_basis.pdf s.htm Case Detection & diagnosis 3 Diagnostic Standards and Classification of Tuberculosis in Adults and Children [1999] 4 Rapid Diagnostic Test for Tuberculosis: What is the Appropriate Use? [1997] 5 Anergy Skin Testing and Preventive Therapy for HIV-Infected Persons: Revised Recommendations. [1997] 6 Guidelines for Using the QuantiFERON - TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection [2003] 7 Screening for Tuberculosis Infection [1996] 8 Guidelines for the diagnosis of latent tuberculosis infection [2002] Treatment & monitoring 9 Treatment of Tuberculosis. American Thoracic Society, CDC, and Infectious Diseases Society of America [2002] 10 Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection [1999] m 10
11 11 Treatment of Tuberculosis guidelines for national programmes - Third edition [2003] df 12 Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria [1997] 13 Treatment of Tuberculosis and Tuberculosis Infection in Adults & Children [1994] 14 Treating the Patient with Tuberculosis: Guidelines for Collaborating with Community Physicians [2003] 15 A guide for Tuberculosis Treatment Supporters [2002] 0.pdf 16 Tuberculosis handbook [1998] 98_253-en.pdf 17 Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection [2003] 18 Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999 [2000] 19 Practice Guidelines for the Treatment of Tuberculosis [2000] 3/000549/ web.pdf 20 Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region. [1999] 21 Chemotherapy and management of tuberculosis in the United Kingdom: recommendations [1998] DOTS 11
12 22 What is DOTS? - A guide to understanding the WHO-recommended TB control strategy known as DOTS [1999] 23 Combating Tuberculosis: Principles for Accelerating DOTS coverage [1999] 24 An Expanded DOTS Framework for effective Tuberculosis Control [2002] 25 Public-Private Mix for DOTS: Practical tools to help implementation [2003] OTS.pdf pdf 5.pdf 26 DOTS for tuberculosis [2001] d47d0/257b42d9ef210e62cc2569ec007cb62f/$FI LE/DOTTBDoc.pdf 27 Guidelines for Initiating a School-Based Directly Observed Therapy Program [2002] 28 Evidence for Action: Lack of Evidence that Directly Observed Therapy (DOT) Improves Cure or Treatment Completion Rates in Patients with Tuberculosis [2001] Prevention and control 29 Control of tuberculosis in the United States [1992] 30 Tuberculosis Control: an Annotated Bibliography [2001] 31 Toman s Tuberculosis: Case detection, treatment and monitoring [2004] f 32 Global Plan to Stop TB [2003] globalplan_en.pdf 33 Involving Private Practitioners in Tuberculosis Control [2001] F/PrivatePractitionnersWHO285.pdf 34 Guidelines for conducting a review of a national tuberculosis programme [1998] 0.pdf 35 European framework to decrease the burden of TB/HIV [2003] 12
13 38 The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States [1996] 39 Progressing Toward Tuberculosis Elimination in Low-Incidence Areas of the United States [2002] 40 Tuberculosis Elimination Revisited: Obstacles, Opportunities, and a Renewed Commitment [1999] 41 Essential Components of a Tuberculosis Prevention and Control Program [1995] 42 Management of Tuberculosis: a Guide for Low Income Countries [2000] 43 Interventions for Tuberculosis Control and Elimination [2002] 44 Tuberculosis Programs Review, Planning, Technical Support: A manual of methods and procedures [1998] 45 Tuberculosis A Manual for Medical Students [2003] 46 A Tuberculosis Guide for Specialist Physicians - part 1 3 [2004] 47 Management, prevention and control of tuberculosis: Guidelines for health care providers Canadian Tuberculosis Standards. 5 th Edition [2000] CoreCurriculumonTB.pdf ent_of_tb.pdf ons.pdf ms.pdf uide.pdf 36 European framework for tuberculosis control and elimination in countries with a low incidence [2002] how=&hits=10&hits=10&resultformat=&fulltext=tu berculosis&andorexactfulltext=and&searchid= _15&stored_search=&FIRSTINDEX=0&sortspec=relev ance&resourcetype=1&journalcode=erj 37 Core Curriculum on Tuberculosis [2000] Guidelines for Tuberculosis Control in New 13
14 Zealand [2003] C256C86006ED394/$File/TBControlGuidelines03.pdf 50 Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000 [2000] 51 Stopping tuberculosis in England [2004] f 52 Tuberculosis Reference Guide [2001] 53 Ending Neglect: Elimination of tuberculosis in the US [2000] 54 Technical Guidelines for Tuberculosis Control [2000] 55 Operational Guidelines for Tuberculosis Control [2000] 56 NGO Guidelines 57 A guide for practicing physicians 58 A guide for medical officers Special groups and vulnerable populations (homeless, refugees, prisoners, etc.) 59 TB control in refugee situations [1997] 60 Guidelines for the control of TB in prisons [1998] 61 Recommendations for Prevention and Control of Tuberculosis among Foreign- Born Persons [1998] 62 Prevention and Control of Tuberculosis in Correctional Facilities [1996] 63 Screening for Tuberculosis and Tuberculosis Infection in High-Risk Populations [1995] 64 Prevention and Control of Tuberculosis Among Homeless Persons [1992] m 65 Guidelines for the investigation and followup of individuals under medical surveillance 14
15 for tuberculosis after arriving in Canada: a summary [2003] Health care workers & nosocomial, occupational transmission 66 Guidelines for Environmental Infection Control in Health-Care [2003] 67 Guidelines for Preventing the transmission of Mycobacterium tuberculosis in Health- Care Facilities [1994] 68 Guidelines for the prevention of tuberculosis in health care facilities in resource-limited settings [1999] pdf 69 Tuberculosis in the workplace [2001] 70 Policy and Procedures for Tuberculosis Screening of Healthcare Workers [1999] reening.pdf 71 Treating Latent Tuberculosis Infection in Key High-Risk Communities 06%20B&subSec=Workplace%20Tools 72 Guidelines for Workplace TB Control [2003] 73 A Guideline for Establishing Effective Practices: Identifying Persons with Infectious TB in the Emergency Department [1999] 74 Institutional Control Measures for Tuberculosis in the Era of Multiple Drug Resistance [1995] Childhood Tuberculosis f rgencyroomguidelines.pdf 75 Management of latent tuberculosis infection in children [2004] 76 Consensus statement of management of Pediatric TB under RNTCP [2003] df 0of%20management%20of%20Paediatric%20TB%20und 15
16 77 Criterios de diagnóstico y tratamiento de la tuberculosis infantil / Diagnostic and therapeutic criteria for the management of tuberculosis in childhood [2002] 78 Consensus Statement on Diagnosis of Childhood Tuberculosis. [2004] er%20rntcp.pdf TB & HIV 79 A guide to monitoring and evaluation for collaborative TB/HIV activities [2004] 2.pdf 80 TB/HIV Clinical Manual, 2 nd Ed [2004] f 81 A strategic framework to decrease the burden of TB/HIV [2002] _hiv_2002_296_en.pdf 82 Interim policy on collaborative TB/HIV activities [2004] 0.pdf 83 Research Brief Preventing Tuberculosis in HIV-infected Persons [2004] ef.pdf 84 TB-HIV:A Guide for Health Worker 85 Guidelines for HIV surveillance among tuberculosis patients Second edition [2004] 86 Policy Statement on Preventive Therapy Against Tuberculosis in People Living with HIV [1998] 87 Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors [2004] MDR-TB 9.pdf /tbhivpolicy.pdf 16
17 88 Guidelines for surveillance of drug resistance in tuberculosis [2003] 89 Anti-Tuberculosis Drug Resistance in the World [2004] 90 National Action Plan to Combat Multidrug- Resistant Tuberculosis [1992] 91 Management of Persons Exposed to Multidrug-Resistant Tuberculosis [1992] 92 Guidelines for the management of drugresistant TB [1997] 93 Multidrug resistant tuberculosis (MDR-TB): Basis for the development of an evidencebased case-management strategy for MDR- TB within the WHO's DOTS strategy [1999] 94 DOTS-Plus: preliminary results and emerging issues [2002] 3_320/surveillance_guidelinespdf.pdf s_report_exec.pdf m m df 60.pdf Laboratory services 95 Technical Guide: Sputum Examination for Tuberculosis by Direct Microscopy in Low Income Countries [2000] 96 Laboratory services in tuberculosis control: Part I: Organization and Management [1998] Laboratory services in tuberculosis control: Part II: Microscopy [1998] Laboratory services in tuberculosis control: Part III: Culture [1998] 97 The Public Health Service National Tuberculosis Reference Laboratory and the National Laboratory Network py_guide.pdf alth_service.pdf 17
GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION
GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1
More informationChapter 1 Overview of Tuberculosis Epidemiology in the United States
Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States... 3 TB Disease Trends in the United
More informationMODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit
MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative
More informationTB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
More information2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges
Outline of what it will take Tuberculosis Elimination 25: Global and Local Challenges Anne Fanning, MD November 9, 211 21 global TB trends, goals How DOTS happens at country level - an exercise New strategies
More informationTUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.
30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE
More informationLatent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers
Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers Who Should Be Screened for Latent Tuberculosis Infection (LTBI)?... 2 What tests are used to screen for LTBI?... 2 How
More informationGlobally, it is well documented that certain
Surveillance Report Characteristics and treatment outcomes of tuberculosis cases by risk groups, Japan, 2007 2010 Kazuhiro Uchimura, a Jintana Ngamvithayapong-Yanai, a Lisa Kawatsu, a Akihiro Ohkado, a
More informationTUBERCULOSIS. Presented By: Public Health Madison & Dane County
TUBERCULOSIS Presented By: Public Health Madison & Dane County What is Tuberculosis? Tuberculosis, or TB, is a disease caused by a bacteria called Mycobacterium tuberculosis. The bacteria can attack any
More informationThe Western Pacific Region faces significant
COMBATING COMMUNICABLE DISEASES A medical technician draws blood for HIV screening in Manila. AFP elimination of mother-to-child transmission of HIV and congenital syphilis was piloted in Malaysia and
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
TB Partial Update Appendix 1 - Scope NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis (partial
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis (partial update) 1.1 Short title Tuberculosis
More informationThe WHO END-TB Strategy
ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who
More informationNew Tuberculosis Guidelines. Jason Stout, MD, MHS
New Tuberculosis Guidelines Jason Stout, MD, MHS Two New Sets of Guidelines Treatment of Drug-Susceptible Tuberculosis Clinical Infectious Diseases 2016; 63(7): e147-e195 Diagnosis of Tuberculosis in Adults
More informationTuberculosis Epidemiology
Tuberculosis Epidemiology TB CLINICAL INTENSIVE COURSE Curry International Tuberculosis Center October 18, 2017 Varsha Hampole, MPH Tuberculosis Control Branch California Department Of Public Health Outline
More informationNew NICE guideline updates recommendations for diagnosing latent tuberculosis
Tel: 0845 003 7782 www.nice.org.uk Ref: 2011/053 PRESS RELEASE New NICE guideline updates recommendations for diagnosing latent tuberculosis The National Institute for Health and Clinical Excellence (NICE)
More informationLATENT TUBERCULOSIS. Robert F. Tyree, MD
LATENT TUBERCULOSIS Robert F. Tyree, MD 1 YK TB OFFICERS Ron Bowerman Elizabeth Roll Mien Chyi (Pediatrics) Cindi Mondesir (Pediatrics) The new guys: Philip Johnson Robert Tyree 2009 CDC TB CASE DEFINITION
More informationQuestions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs
Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs What causes TB? TB is caused by the bacterium Mycobacterium tuberculosis. Although it can cause disease in
More informationTB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE)
TB IN EMERGENCIES Department of Epidemic and Pandemic Alert and Response (EPR) Health Security and Environment Cluster (HSE) (Acknowledgements WHO Stop TB Programme WHO/STB) 1 Why TB? >33% of the global
More informationOverview of the WHO policy on TB Infection Control and practical aspects and implementation tools for effective IC measures in Health facilities
Overview of the WHO policy on TB Infection Control and practical aspects and implementation tools for effective IC measures in Health facilities Dr. M. Angélica Salomão Medical Officer DOTS Expansion &
More informationPrimer on Tuberculosis (TB) in the United States
Primer on Tuberculosis (TB) in the United States The purpose of this primer is to provide instructors who have no prior background in TB research or clinical care with basic knowledge that they may find
More informationTB Infection Control Policy. Scaling-up the implementation of collaborative TB/HIV activities in the Region of the
TB Infection Control Policy Scaling-up the implementation of collaborative TB/HIV activities in the Region of the Infection Control is aimed at minimizing the risk of TB transmission within populations
More informationPrinciple of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos
Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases
More informationTB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationInternational Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007
TB Along the US/Mexico Border El Paso, Texas August 22-23, 2007 International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 Barbara J Seaworth MD Medical Director Heartland National
More informationPediatric Tuberculosis in Los Angeles County: An Update
Pediatric Tuberculosis in Los Angeles County: An Update Julie Higashi, MD PhD Director, Tuberculosis Control Program March 2, 2019 0 Pediatricians will be the driving force of TB elimination in California
More informationTB Control in Finland - the role of THL
TB Control in Finland - the role of THL Hanna Soini THL, Department of Health Security 1 TB in Finland 1950-2014 12000 10000 8000 6000 TB ulkomaalaiset TB yhteensä 4000 2000 0 1950 1955 1960 1965 1970
More information2016 Annual Tuberculosis Report For Fresno County
206 Annual Tuberculosis Report For Fresno County Cases Rate per 00,000 people 206 Tuberculosis Annual Report Fresno County Department of Public Health (FCDPH) Tuberculosis Control Program Tuberculosis
More informationNguyen Van Hung (NTP, Viet Nam)
Technical Consultation Meeting on the Programmatic Management of Latent Tuberculosis Infection 31 August-1 September 2017, Seoul, Republic Korea Adopting new LTBI diagnostics at country level: perspective
More informationExpanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination
IUATLD North American Region Conference February 24, 2017 Vancouver, BC Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination Philip LoBue, MD National Center
More informationTB BASICS: PRIORITIES AND CLASSIFICATIONS
TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE NOVEMBER 1-4, 2016 TB BASICS: PRIORITIES AND CLASSIFICATIONS LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1.
More informationUNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision
UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision Updated version following MERG recommendations Context In light of country reports, regional workshops and comments received by a
More information10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose
Disclosures Updates in Tuberculosis I have nothing to disclose Chris Keh, MD Assistant Clinical Professor, Division of Infectious Diseases, UCSF TB Controller, TB Prevention and Control Program, Population
More informationGuidelines for TB contact tracing in Pacific Island countries and territories
Guidelines for TB contact tracing in Pacific Island countries and territories Background Tuberculosis (TB) continues to be a public health issue of major significance around the world. The World Health
More informationDRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION
JOURNAL OF PREVENTIVE MEDICINE 2008; 16(3-4): 3-9 Inviting Editorial DRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION Harshad Thakur Centre for Health Policy, Planning and Management,
More informationTB trends and TB genotyping
Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures
More informationControlling TB in the era of HIV
Controlling TB in the era of HIV Christy Hanson, PhD, MPH TB Research Advisor Amy Bloom, MD TB/HIV Advisor TB Incidence rates highest in Africa Estimated new TB cases (all forms) per 100 000 population
More informationTuberculosis and BCG
Tuberculosis and BCG Steve Graham Centre for International Child Health University of Melbourne Department of Paediatrics Royal Children s Hospital Melbourne Child Lung Health International Union Against
More informationThe need for new TB diagnostics in children and the way forward
The need for new TB diagnostics in children and the way forward Steve Graham Centre for International Child Health University of Melbourne Department of Paediatrics Royal Children s Hospital Melbourne
More informationTuberculosis Procedure ICPr016. Table of Contents
Tuberculosis Procedure ICPr016 Table of Contents Tuberculosis Procedure ICPr016... 1 What is Tuberculosis?... 2 Any required definitions/explanations... 2 NHFT... 2 Tuberculosis (TB)... 3 Latent TB...
More informationThe Epidemiology of Tuberculosis in Minnesota,
The Epidemiology of Tuberculosis in Minnesota, 2011 2015 Minnesota Department of Health Tuberculosis Prevention and Control Program (651) 201-5414 Tuberculosis surveillance data for Minnesota are available
More informationDrug-resistant Tuberculosis
page 1/6 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Context - Tuberculosis (TB) is an infectious disease that affects a growing number of
More informationIntensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite
Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Riga East Clinical hospital, Centre for tuberculosis and lung diseases. Head of outpatient department.
More informationSubstance Abuse and Tuberculosis Springfield, IL April 27, 2011
5/6/2011 Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Epidemiology of Substance Abuse and Tuberculosis: Where is the Problem? Debra Stephens, RN, BSN, MPH April 27, 2011 Debra Stephens,
More informationProgrammatic management of latent TB infection: Global perspective and updates. Haileyesus Getahun, MD, MPH, PhD.
Programmatic management of latent TB infection: Global perspective and updates Haileyesus Getahun, MD, MPH, PhD. What is latent TB infection? A state of persistent immune response to stimulation by Mycobacterium
More informationThe Role of Rifampin for the Treatment of Latent TB Infection. Introduction. Introduction
The Role of Rifampin for the Treatment of Latent TB Infection March 26, 2008 Alfred A. Lardizabal, MD Associate Professor of Medicine New Jersey Medical School Global Tuberculosis institute Treatment of
More informationCatalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030
Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 Introduction The Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 provides an overarching policy framework
More informationLatent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016
Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No
More informationBasic Overview of Tuberculosis Epidemiology in the Czech Republic in 2017
Centre for the development of technology platform used in registries of the National Health Information System, modernisation of data mining within these registries and extending their information capacity.
More informationOutline. Tuberculosis (TB) Medical Evaluation for TB 5/5/2014. Chest Radiograph with Lower Lobe Cavity
Jean Beinemann RN, Terri Boxrucker RN, and LT Dee Dee Downie MPH Outline The disease The outbreak The response The conclusions May 18, 2014 Wisconsin Public Health Association Annual Meeting Tuberculosis
More informationTuberculosis Populations at Risk
Tuberculosis Populations at Risk One-third of the world is infected with TB, an average of one new infection per second Two million people died from tuberculosis in 2010, 1 every 20 seconds TB is the leading
More informationChapter 7 Tuberculosis (TB)
Chapter 7 Tuberculosis (TB) TB infection vs. TB disease Information about TB TB skin testing Active TB disease TB risk factors Role of Peel Public Health in TB prevention and control Environmental and
More informationPeggy Leslie-Smith, RN
Peggy Leslie-Smith, RN EMPLOYEE HEALTH DIRECTOR - AVERA TRAINING CONTENT 1. South Dakota Regulations 2. Iowa Regulations 3. Minnesota Regulations 4. Interferon Gamma Release Assay (IGRA)Testing 1 SOUTH
More informationWeekly. August 8, 2003 / 52(31);
Weekly August 8, 2003 / 52(31);735-739 Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis
More informationTuberculosis in Chicago 2007
City of Chicago Communicable Disease Information Department of Public Health Richard M. Daley, Mayor May 2008 Terry Mason, MD, FACS, Commissioner www.cityofchicago.org/health/ West Side Center For Disease
More informationRevised National Tuberculosis Control Programme
Revised National Tuberculosis Control Programme 1 OUTLINE OF PRESENTATION Introduction Burden Of The Disease Evolution Of RNTCP Goals And Objectives Of RNTCP DOTS Stop TB Strategy Organization RNTCP Endorsed
More informationRevised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor
Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor Global scenario*: Burden of TB Incidence : 9.6 million (58% SEAR and Western Pacific) Deaths : 1.5 million
More informationRevitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment
17 th TB/HIV Core Group meeting, Beijing, China. November 11, 2011 Revitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment Haileyesus Getahun Stop TB Department WHO Outline
More informationTuberculosis. New TB diagnostics. New drugs.new vaccines. Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012
Tuberculosis New TB diagnostics. New drugs.new vaccines Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012 Tuberculosis (TB )is a bacterial disease caused by Mycobacterium tuberculosis (occasionally
More informationAn Investigation into Tuberculosis Control in India. Disa Linden-Perlis, Karin Wickman, Saya Kato & Ebony Blanch
An Investigation into Tuberculosis Control in India Disa Linden-Perlis, Karin Wickman, Saya Kato & Ebony Blanch Mycobacterium tuberculosis Taken from Max Planck Institute for Infection Biology /Volker
More informationAnnex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)
IMPACT INDICATORS (INDICATORS PER GOAL) HIV/AIDS TUBERCULOSIS MALARIA Reduced HIV prevalence among sexually active population Reduced HIV prevalence in specific groups (sex workers, clients of sex workers,
More informationLATENT TUBERCULOSIS SCREENING AND TREATMENT:
LATENT TUBERCULOSIS SCREENING AND TREATMENT: TB or not TB Christopher Kwong, MD and William Rifkin, MD Week 14 Educational Objectives: 1. Understand who should be screened for latent TB infection and why
More informationCMH Working Paper Series
CMH Working Paper Series Paper No. WG5 : 8 Title Interventions to reduce tuberculosis mortality and transmission in low and middle-income countries: effectiveness, cost-effectiveness, and constraints to
More informationAll you need to know about Tuberculosis
All you need to know about Tuberculosis What is tuberculosis? Tuberculosis is an infectious disease that usually affects the lungs. Doctors make a distinction between two kinds of tuberculosis infection:
More information2017/2018 Annual Volunteer Tuberculosis Notice
Lewis Center for Educational Research Academy for Academic Excellence Norton Science and Language Academy Business Offices 17500 Mana Road Apple Valley, CA 92307 E-mail: hr@lcer.org 760-946-5414 Fax 760-946-9193
More informationTB Prevention Who and How to Screen
TB Prevention Who and How to Screen 4.8.07. IUATLD 1st Asia Pacific Region Conference 2007 Dr Cynthia Chee Dept of Respiratory Medicine / TB Control Unit Tan Tock Seng Hospital, Singapore Cycle of Infection
More informationArizona Annual Tuberculosis Surveillance Report
Arizona Annual Tuberculosis Surveillance Report 2014 Table of Contents I. Executive Summary 1 II. Case Rates 3 III. Cases and Case Rates by Race and Ethnicity 4 IV. Cases by Gender 4 V. Cases and Case
More informationTuberculosis in Alameda County, 2014 Alameda County Public Health Department
Tuberculosis in Alameda, 214 Alameda Public Health Department Tuberculosis (TB) is a preventable and curable disease that remains one of the leading causes of death worldwide. TB is a communicable disease
More informationLa Lotta alla Tubercolosi. Matteo Zignol and Mario C. Raviglione Stop TB Department WHO, Geneva, Switzerland. Geneva March 2012
La Lotta alla Tubercolosi Matteo Zignol and Mario C. Raviglione Stop TB Department WHO, Geneva, Switzerland Geneva 19-20 March 2012 Overview of the presentation The global burden of tuberculosis The WHO
More informationThese recommendations will remain in effect until the national shortage of PPD solution has abated.
Maryland Recommendations Regarding the National Shortage of Purified Protein Derivative (PPD) Solution; Attachment to Health Officer Memorandum National Shortages of Tubersol and Aplisol for TB Skin Testing;
More informationProgrammatic management of LTBI : a two pronged approach for ending the TB epidemic. Haileyesus Getahun Global TB Programme WHO/HQ
Programmatic management of LTBI : a two pronged approach for ending the TB epidemic Haileyesus Getahun Global TB Programme WHO/HQ What is latent TB infection? A state of persistent immune response to stimulation
More informationBasic Overview of Tuberculosis Epidemiology in the Czech Republic in 2015
Centre for the development of technology platform used in registries of the National Health Information System, modernisation of data mining within these registries and extending their information capacity.
More informationGuidance on Matching Funds: Tuberculosis Finding the Missing People with TB
February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each
More informationU.S. Preventive Services Task Force Recommendation Statement: Screening for Latent Tuberculosis Infection (LTBI) in Adults
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention U.S. Preventive Services Task Force Recommendation Statement: Screening for Latent Tuberculosis Infection (LTBI) in Adults Centers
More informationCDC IMMIGRATION REQUIREMENTS:
CDC IMMIGRATION REQUIREMENTS: Technical Instructions for Tuberculosis Screening and Treatment Using Cultures and Directly Observed Therapy October 1, 2009 Table of Contents Preface...i Tuberculosis Screening...1
More informationWhy can t we eliminate tuberculosis?
Why can t we eliminate tuberculosis? Neil W. Schluger, M.D. Professor of Medicine, Epidemiology and Environmental Health Sciences Columbia University Chief Scientific Officer World Lung Foundation Current
More informationContact Follow-Up and Treatment of LTBI in Households of Infectious Cases in Pakistan
Contact Follow-Up and Treatment of LTBI in Households of Infectious Cases in Pakistan 17 th Annual Conference, The Union-North American Region, Vancouver, Canada. 28 February 2013 Farhana Amanullah Director
More informationPlease distribute a copy of this information to each provider in your organization.
HEALTH ADVISORY TO: Physicians and other Healthcare Providers Please distribute a copy of this information to each provider in your organization. Questions regarding this information may be directed to
More informationWORLD HEALTH ORGANIZATION
PACIFIC STRATEGIC PLAN to STOP TB 2000 WORLD HEALTH ORGANIZATION Western Pacific Regional Office PACIFIC STRATEGIC PLAN TO STOP TB World Health Organization Western Pacific Regional Office PACIFIC STRATEGIC
More informationThe American Experience with TB Elimination
Reaching the Goal of TB Elimination by 2035 March 3, 2015 The American Experience with TB Elimination John Jereb, M.D. Medical officer Division of Tuberculosis Elimination National Center for HIV/AIDS,
More informationFundamentals of Tuberculosis (TB)
TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported
More informationUNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS ABSTRACT
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS ABSTRACT Epidemiological aspects of tuberculosis disease in disadvantaged population groups in Dolj county in the period 2006-2011 PhD Supervisor,
More informationTB EPIDEMIOLOGY: IMPACT ON CHILDREN. Anneke C. Hesseling Desmond Tutu TB Centre Department Paediatrics and Child Health Stellenbosch University
TB EPIDEMIOLOGY: IMPACT ON CHILDREN Anneke C. Hesseling Desmond Tutu TB Centre Department Paediatrics and Child Health Stellenbosch University Robert Koch 1843-1910 Discovered M. tuberculosis 1882 TB deaths
More informationMycobacterial Infections: What the Primary Provider Should Know about Tuberculosis
Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening
More informationScott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer
Tuberculosis in the 21 st Century Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Feedback Poll In my opinion, the recent media coverage of
More informationTuberculosis in Malta and the school BCG vaccination programme
Original Article Tuberculosis in Malta and the school BCG vaccination programme Brian Farrugia, Victoria Sant Angelo, Joseph Cacciottolo Abstract Background: Malta has one of the lowest incidence rates
More informationCOFM Immunization Policy
COUNCIL OF ONTARIO FACULTIES OF MEDICINE An affiliate of the Council of Ontario Universities COFM Immunization Policy This policy applies to all undergraduate medical students attending an Ontario medical
More informationThe United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America
The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America Mike Segar / Reuters Executive Summary Context On 26 September 2018, the United Nations
More informationTB Transmission, Pathogenesis & Infection Control
TB Transmission, Pathogenesis & Infection Control Bradley Allen, MD, PhD, FACP, FIDSA. 2014 MFMER slide-1 Disclosures Medical Consultant, TB Control Program Indiana State Department of Health Past clinical
More informationUN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022
UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022 UNHLM ON TB KEY TARGETS FOR 2022 WE, HEADS OF STATE AND GOVERNMENT AND REPRESENTATIVES OF STATES AND GOVERNMENTS ASSEMBLED AT THE UNITED NATIONS
More informationChapter 5 Treatment for Latent Tuberculosis Infection
Chapter 5 Treatment for Latent Tuberculosis Infection Table of Contents Chapter Objectives.... 109 Introduction.... 111 Candidates for the Treatment of LTBI... 112 LTBI Treatment Regimens.... 118 LTBI
More informationIbrahim Abubakar, MBBS, MSc, PhD, FFPH
Ibrahim Abubakar, MBBS, MSc, PhD, FFPH Head of Section / Consultant Epidemiologist Tuberculosis Section HPA Centre for Infections Colindale London UK Outline TB epidemiological situation UK data collection
More informationIMPACT OF IMPROVED TREATMENT SUCCESS ON THE PREVALENCE OF TB IN A RURAL COMMUNITY BASED ON ACTIVE SURVEILLANCE
Original Article IMPACT OF IMPROVED TREATMENT SUCCESS ON THE PREVALENCE OF TB IN A RURAL COMMUNITY BASED ON ACTIVE SURVEILLANCE P. G. Gopi, R. Subramani, V. Chandrasekaran, T. Santha and P. R. Narayanan
More informationTB in Corrections Phoenix, Arizona
TB in Corrections Phoenix, Arizona March 24, 2011 Treatment of Latent TB Infection Renuka Khurana MD, MPH March 24, 2011 Renuka Khurana, MD, MPH has the following disclosures to make: No conflict of interests
More informationStop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan
Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan 2006-2015 Background Current threat and status of the global epidemic of multidrug resistant tuberculosis (MDR-TB) Along with HIV/AIDS, MDR-TB
More informationNew Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents
New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents Jeffrey R. Starke, M.D. Professor of Pediatrics Baylor College of Medicine [With great thanks to Andrea
More informationTuberculosis in Alameda County, 2012
Tuberculosis in Alameda County, 212 Alameda County Public Health Department Tuberculosis Overview Tuberculosis (TB) is a preventable and curable disease that remains one of the leading causes of death
More informationTB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology
TB EPIDEMIOLOGY TB Clinical Intensive Course Curry International Tuberculosis Center September 30, 2015 Varsha Nimbal, MPH Tuberculosis Control Branch California Department of Public Health 1 Outline TB
More information